Occupational Therapy in Palliative Care

NCT ID: NCT02521194

Last Updated: 2020-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

86 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-11-13

Study Completion Date

2020-01-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this research study is to learn if inpatient occupational therapy can help patients in the Palliative Care Unit (PCU).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Caregivers Consent:

If you agree to take part in this study, you will complete a questionnaire about your opinion on the inpatient occupational therapy session the patient (person you are caring for) received. It should take about 10 minutes to complete the questionnaire. You will be left alone in a room to complete the questionnaire.

Length of Study:

Your participation on this study will be over after you complete the questionnaire.

This is an investigational study.

50 patients and up to 50 caregivers will take part in this study. All will be enrolled at MD Anderson.

Patients Consent:

If you agree to take part in this study, you will complete a questionnaire about your opinion of the inpatient occupational therapy session you just had. The questionnaire should take about 10 minutes to complete. You will be left alone in the room to complete the questionnaire.

Length of Study:

You participation on this study will be over after you complete the questionnaire.

This is an investigational study.

50 patients and up to 50 caregivers will take part in this study. All will be enrolled at MD Anderson.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Advanced Cancers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caregiver Questionnaire

Questionnaire completion regarding opinion on the inpatient occupational therapy session person being cared for received.

Group Type EXPERIMENTAL

Questionnaire

Intervention Type BEHAVIORAL

Questionnaire completion regarding opinion of the inpatient occupational therapy session patient received.

Patient Questionnaire

Questionnaire completion regarding opinion of the inpatient occupational therapy session patient received.

Group Type EXPERIMENTAL

Questionnaire

Intervention Type BEHAVIORAL

Questionnaire completion regarding opinion of the inpatient occupational therapy session patient received.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Questionnaire completion regarding opinion of the inpatient occupational therapy session patient received.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Survey

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients must have an inpatient occupational therapy (OT) order and be able to tolerate an OT session as judged by the attending physician
2. Patients with cancer admitted to inpatient acute palliative care unit
3. Caregiver participation is optional, but must be identified as the primary caregiver in order to complete the Caregiver Satisfaction Survey.
4. Caregiver (if participating) must be present during the session.
5. Patient (and caregiver (if participating) must be 18 years of age or older.
6. Both patient (and caregiver if participating) must be able to understand, read, write and speak English.
7. Both patient and caregiver (if participating) must sign an Informed Consent Form.

Exclusion Criteria

1. Patients or caregivers with physical limitations (visual or motor impairment) causing inability to read, complete or sign the consent form and survey.
2. Patients or caregivers who the attending physician deems unable to participate due to poor cognitive capacity or acute physical distress.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

M.D. Anderson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul W. Walker, MD

Role: PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Texas MD Anderson Cancer Center

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mdanderson.org

University of Texas MD Anderson Cancer Center Website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-0350

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.